Major Breakthrough in Treatment for Severe Hemophilia A


This video from Wochit News is all about a new treatment for severe hemophilia A. The Children’s Hospital of Los Angeles, California, has developed a breakthrough treatment that can reduce the bleeding episodes in people living with hemophilia A by up to 90 percent.

MORE: Emicizumab shows promise in trials as a preventative treatment for hemophilia A patients of all ages

Currently, people who have severe hemophilia A need to have hour-long intravenous clotting factor treatments three times a week to help prevent bleeds. The research team at the hospital found that the monoclonal antibody emicizumab dramatically decreased the bleeding episodes for hemophilia A patients, and the treatment only needs to be given once a week by subcutaneous injection.

MORE: Chugai Pharmaceutical files new drug application for hemophilia A treatment emicizumab

Hemophilia News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published. Required fields are marked *